Case Control Study
Copyright ©The Author(s) 2017.
World J Gastrointest Endosc. Apr 16, 2017; 9(4): 162-170
Published online Apr 16, 2017. doi: 10.4253/wjge.v9.i4.162
Table 1 Baseline characteristics of study population (n = 80)
ParameterLRYGB group (n = 40)LSG group (n = 40)P value
Age (yr)44.6 ± 10.244.8 ± 10.2NS
Gender
Female, n (%)29 (72.5%)29 (72.5%)NS
Male, n (%)11 (27.5%)11 (27.5%)NS
Weight (kg)109.9 ± 13.9113.6 ± 15.2NS
Body mass index (kg/m2)43.9 ± 5.545.8 ± 4.8NS
Excess weight (kg)46.9 ± 12.751.3 ± 12.2NS
Comorbidities
Type 2 diabetes mellitus, n (%)27 (67.5%)27 (67.5%)NS
Patients on insulin5 (18.5%)5 (18.5%)NS
aNumber of OHA2.2 ± 0.71.8 ± 0.7
abDuration (yr)7 (5-7)5 (3-7)
Hypertension, n (%)25 (62.5%)23 (57.5%)NS
Number of AHA1.7 ± 0.71.7 ± 0.8NS
OSAS, n (%)7 (17.5%)2 (5%)NS
Hypothyroidism, n (%)11 (27.5%)7 (17.5%)NS
Thyroxine dosage (µg/d)90.9 ± 25.789.9 ± 31.8NS
GERD, n (%)7 (17.5%)4 (10%)NS